michigandaily.com Thursday, May 10, 2018 INDEX Vol. CXXVII, No. 116 | © 2018 The Michigan Daily michigandaily.com NEWS .................................... OPINION ............................... ARTS ...................................... MiC......................................... SPORTS................................ MICHIGAN IN COLOR Defend DACA Immigrant protections are at risk under Donald Trump >> SEE PAGE 9 NEWS Racist list update University investigation of crass and racist Elite Bar Crawl list is at a stand still. >> SEE PAGE 2 OPINION Let’s Make a Pact Hannah Harshe explores how different standards are set for men and women at work. >> SEE PAGE 5 ARTS ‘This is America’ Childish Gambino releases confrontational new single. >> SEE PAGE 7 SPORTS Softball prevails over Ohio State On Senior Day, the Michgan softball team defeated its biggest rival >> SEE PAGE 12 inside 2 4 6 9 10 See RESEARCH, Page 3 U-M sued by Speech First over Bias Response Team Organization files injunction against “U” over free speech By GRACE KAY Summer Managing News Editor The University of Michigan is the first university in the nation to receive a federal lawsuit regarding the effect the U-M Bias Response Team might have on speech freedom on campus. On Tuesday, Speech First, an organization of students, citizens and alumni advocating free speech on college campuses, filed a federal lawsuit against the University, challenging the Bias Response Team’s accordance with the U.S. Constitution and calling for a permanent injunction prohibiting the Bias Response Team from investigating students. Speech First President Nicole Neily said the organization is filing the injunction against the University based on three main factors. “We have multiple members of the organization at the University,” Neily said. “The University of Michigan also has a combination of a very bad speech code that is very vague, a very active bias response team that is very proud of its achievements because it keeps a log and we have numbers there, though not all were listed in the complaint. These were the three things we needed.” This is not the first time the University’s speech code and freedom of speech has been called into question. In 2017, hundreds of students flooded into the Michigan League to voice displeasure with the Michigan Political Union’s decision to debate the Black Lives Matter movement as harmful to racial relations, causing many people outside of the University to question whether unpopular voices or perspectives can be heard at the University. Similarly, when Charles Murray, author of “The Bell Curve,” a book which argues for the concept of racial differences in intelligence, spoke at the University, several students attempted to shut down the event. The University has experienced controversy on the speech code as far back as 1989. A 1989 case, Doe v. University of Michigan, determined the University’s 1988 hate speech law violated the constitutional right to free speech. Neily claims freedom of speech and the campus atmosphere are stifled by vague and subjective speech codes and bias response teams. “It is very difficult to have a system in place (like a bias response team) without having a mechanism that kills speech,” Neily said. “I fail to see how you can have that kind of system without entirely stifling free speech.” According to the University’s Bias Response Team website, a bias incident is anything that discriminates against a community based on their identity. New pill can detect breast cancer Researchers at “U” develop pill to reduce overtreatment By NATSAHA PIETRUSCHKA Daily Staff Reporter Researchers at the University of Michigan are developing a new diagnostic pill that improves conventional detection methods and reduces the overtreatment of breast cancer. The U-M research team, led by Greg Thurber, chemical engineering assistant professor, is refining an oral pill that dissolves in the bloodstream and illuminates tumors under infrared light. According to Thurber, many women who have breast cancer tumors would never suffer from the disease but are treated anyway. Mammography, a common form of breast cancer detection, determines the existence of a tumor but not if the tumor is cancerous or benign. Chemicals in the new pill are able to bind to cancerous tissue and light up under infrared light to inform physicians where cancerous tumors are located. Thurber says that knowing information at the molecular level is at the core of effective cancer detection. “We’ve known from decades of research in cancer biology that it’s really a molecular disease, so what’s nice about our approach is that you’re actually getting molecular information,” Thurber said. The pill is an alternative to mammograms or other methods such as magnetic resonance imaging and ultrasounds. According to Thurber, mammograms can sometimes be inaccurate, as they may miss tumors in women with dense breast tissue. Thurber believes his team’s method would be useful at spotting tumors in patients where mammograms don’t work well. See LAWSUIT, Page 3 DANYEL THARAKAN / DAILY ONE-HUNDRED-TWENTY SEVEN YEARS OF EDITORIAL FREEDOM RESEARCH